ENOS activation mediated by AMPK after stimulation of endothelial cells with histamine or thrombin is dependent on LKB1

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 2, 2011, Pages 322-331

  Thors, Brynhildur ^a   Halldórsson, Haraldur ^a,b   Thorgeirsson, Gudmundur ^a,b  

^a UNIVERSITY OF ICELAND   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

AMPK; Endothelial cells; ENOS; Histamine; LKB1

Indexed keywords

ACTIN; ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; AMP ACTIVATED PROTEIN KINASE ALPHA1; AMP ACTIVATED PROTEIN KINASE ALPHA2; CALCIMYCIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE REGULATED PROTEIN 78; HISTAMINE; PROTEIN KINASE LKB1; PROTEIN P40; SMALL INTERFERING RNA; THROMBIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE SILENCING; HUMAN; HUMAN CELL; MONOLAYER CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; AMP-ACTIVATED PROTEIN KINASES; BENZIMIDAZOLES; CALCIMYCIN; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE; CELLS, CULTURED; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HEMOSTATICS; HISTAMINE; HISTAMINE AGONISTS; HUMANS; IMMUNOBLOTTING; NAPHTHALIMIDES; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; THROMBIN; UMBILICAL VEINS;

EID: 78650925938     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.12.001     Document Type: Article

References (43)

1. Yang Z., Ming X.F. Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin. Med. Res. 2006, 4:53-65.
2. Li H., Forstermann U. Nitric oxide in the pathogenesis of vascular disease. J. Pathol. 2000, 190:244-254.
3. Sessa W.C. eNOS at a glance. J. Cell Sci. 2004, 117:2427-2429.
4. Fleming I., Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 284:R1-R12.
5. Fulton D., Gratton J.P., Sessa W.C. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough?. J. Pharmacol. Exp. Ther. 2001, 299:818-824.
6. Morrow V.A., Foufelle F., Connell J.M., Petrie J.R., Gould G.W., Salt I.P. Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells. J. Biol. Chem. 2003, 278:31629-31639.
7. Davis B.J., Xie Z., Viollet B., Zou M.H. Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes 2006, 55:496-505.
8. Boyle J.G., Logan P.J., Ewart M.A., Reihill J.A., Ritchie S.A., Connell J.M., Cleland S.J., Salt I.P. Rosiglitazone stimulates nitric oxide synthesis in human aortic endothelial cells via AMP-activated protein kinase. J. Biol. Chem. 2008, 283:11210-11217.
9. Cheng K.K., Lam K.S., Wang Y., Huang Y., Carling D., Wu D., Wong C., Xu A. Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells. Diabetes 2007, 56:1387-1394.
10. Reihill J.A., Ewart M.A., Hardie D.G., Salt I.P. AMP-activated protein kinase mediates VEGF-stimulated endothelial NO production. Biochem. Biophys. Res. Commun. 2007, 354:1084-1088.
11. Martinelli R., Gegg M., Longbottom R., Adamson P., Turowski P., Greenwood J. ICAM-1-mediated endothelial nitric oxide synthase activation via calcium and AMP-activated protein kinase is required for transendothelial lymphocyte migration. Mol. Biol. Cell 2009, 20:995-1005.
12. Nagata D., Mogi M., Walsh K. AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J. Biol. Chem. 2003, 278:31000-31006.
13. Fisslthaler B., Fleming I. Activation and signaling by the AMP-activated protein kinase in endothelial cells. Circ. Res. 2009, 105:114-127.
14. Quintero M., Colombo S.L., Godfrey A., Moncada S. Mitochondria as signaling organelles in the vascular endothelium. Proc. Natl Acad. Sci. USA 2006, 103:5379-5384.
15. Thors B., Halldorsson H., Jonsdottir G., Thorgeirsson G. Mechanism of thrombin mediated eNOS phosphorylation in endothelial cells is dependent on ATP levels after stimulation. Biochim. Biophys. Acta 2008, 1783:1893-1902.
16. Thors B., Halldorsson H., Thorgeirsson G. Thrombin and histamine stimulate endothelial nitric-oxide synthase phosphorylation at Ser1177 via an AMPK mediated pathway independent of PI3K-Akt. FEBS Lett. 2004, 573:175-180.
17. Stahmann N., Woods A., Carling D., Heller R. Thrombin activates AMP-activated protein kinase in endothelial cells via a pathway involving Ca2+/calmodulin-dependent protein kinase kinase beta. Mol. Cell. Biol. 2006, 26:5933-5945.
18. Stahmann N., Woods A., Spengler K., Heslegrave A., Bauer R., Krause S., Viollet B., Carling D., Heller R. Activation of AMP-activated protein kinase by vascular endothelial growth factor mediates endothelial angiogenesis independently of nitric-oxide synthase. J. Biol. Chem. 2010, 285:10638-10652.
19. Hawley S.A., Boudeau J., Reid J.L., Mustard K.J., Udd L., Makela T.P., Alessi D.R., Hardie D.G. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2003, 2:28.
20. Gudmundsdottir I.J., Halldorsson H., Magnusdottir K., Thorgeirsson G. Involvement of MAP kinases in the control of cPLA(2) and arachidonic acid release in endothelial cells. Atherosclerosis 2001, 156:81-90.
21. Bain J., Plater L., Elliott M., Shpiro N., Hastie C.J., McLauchlan H., Klevernic I., Arthur J.S., Alessi D.R., Cohen P. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 2007, 408:297-315.
22. Dong Y., Zhang M., Liang B., Xie Z., Zhao Z., Asfa S., Choi H.C., Zou M.H. Reduction of amp-activated protein kinase {alpha}2 increases endoplasmic reticulum stress and atherosclerosis in vivo. Circulation 2010, 121:792-803.
23. Hardie D.G. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat. Rev. Mol. Cell Biol. 2007, 8:774-785.
24. Stahmann N., Woods A., Spengler K., Heslegrave A., Bauer R., Krause S., Viollet B., Carling D., Heller R. Activation of AMP-activated protein kinase by vascular endothelial growth factor mediates endothelial angiogenesis independent of no synthase. J Biol Chem. 2010, 285:10638-10652.
25. Woods A., Dickerson K., Heath R., Hong S.P., Momcilovic M., Johnstone S.R., Carlson M., Carling D. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2005, 2:21-33.
26. Momcilovic M., Hong S.P., Carlson M. Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J. Biol. Chem. 2006, 281:25336-25343.
27. Herrero-Martin G., Hoyer-Hansen M., Garcia-Garcia C., Fumarola C., Farkas T., Lopez-Rivas A., Jaattela M. TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells. EmboJ. 2009, 28:677-685.
28. Sanders M.J., Grondin P.O., Hegarty B.D., Snowden M.A., Carling D. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem. J. 2007, 403:139-148.
29. Woods A., Johnstone S.R., Dickerson K., Leiper F.C., Fryer L.G., Neumann D., Schlattner U., Wallimann T., Carlson M., Carling D. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 2003, 13:2004-2008.
30. Fogarty S., Hawley S.A., Green K.A., Saner N., Mustard K.J., Hardie D.G. Calmodulin-dependent protein kinase kinase-beta activates AMPK without forming a stable complex: synergistic effects of Ca2+ and AMP. Biochem J 2010, 426:109-118.
31. Hawley S.A., Pan D.A., Mustard K.J., Ross L., Bain J., Edelman A.M., Frenguelli B.G., Hardie D.G. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2005, 2:9-19.
32. Thors B., Halldorsson H., Clarke G.D., Thorgeirsson G. Inhibition of Akt phosphorylation by thrombin, histamine and lysophosphatidylcholine in endothelial cells. Differential role of protein kinase C, Atherosclerosis 2003, vol. 168:245-253.
33. Song P., Xie Z., Wu Y., Xu J., Dong Y., Zou M.H. Protein kinase Czeta-dependent LKB1 serine 428 phosphorylation increases LKB1 nucleus export and apoptosis in endothelial cells. J. Biol. Chem. 2008, 283:12446-12455.
34. Xie Z., Dong Y., Scholz R., Neumann D., Zou M.H. Phosphorylation of LKB1 at serine 428 by protein kinase C-zeta is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells. Circulation 2008, 117:952-962.
35. Esteve-Puig R., Canals F., Colome N., Merlino G., Recio J.A. Uncoupling of the LKB1-AMPKalpha energy sensor pathway by growth factors and oncogenic BRAF. PLoS ONE 2009, 4:e4771.
36. Zheng B., Jeong J.H., Asara J.M., Yuan Y.Y., Granter S.R., Chin L., Cantley L.C. Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation. Mol. Cell 2009, 33:237-247.
37. Mount P.F., Hill R.E., Fraser S.A., Levidiotis V., Katsis F., Kemp B.E., Power D.A. Acute renal ischemia rapidly activates the energy sensor AMPK but does not increase phosphorylation of eNOS-Ser1177. Am. J. Physiol. Ren. Physiol. 2005, 289:F1103-F1115.
38. Zhang J., Xie Z., Dong Y., Wang S., Liu C., Zou M.H. Identification of nitric oxide as an endogenous activator of the AMP-activated protein kinase in vascular endothelial cells. J. Biol. Chem. 2008, 283:27452-27461.
39. Ron D., Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 2007, 8:519-529.
40. Colombo S.L., Moncada S. AMPKalpha1 regulates the antioxidant status of vascular endothelial cells. Biochem. J. 2009, 421:163-169.
41. Kukidome D., Nishikawa T., Sonoda K., Imoto K., Fujisawa K., Yano M., Motoshima H., Taguchi T., Matsumura T., Araki E. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes 2006, 55:120-127.
42. Wang S., Zhang M., Liang B., Xu J., Xie Z., Liu C., Viollet B., Yan D., Zou M.H. AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26 S proteasomes. Circ. Res. 2010, 106:1117-1128.
43. Kahn B.B., Alquier T., Carling D., Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005, 1:15-25.